Male Breast Carcinoma Completed Phase 2 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00118157Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenTreatment